John E. Edwards
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 132
- Parasitic Diseases Research and Treatment 14
- Epidemiology 96
- Fungal Infections and Studies 80
- Nail Diseases and Treatments 11
- Co-authors
- Brad Spellberg (45 shared papers)Ashraf S. Ibrahim (75 shared papers)Scott G. Filler (51 shared papers)John S. Bradley (6 shared papers)David N. Gilbert (5 shared papers)John Rex (10 shared papers)George H. Talbot (3 shared papers)Michael Scheld (2 shared papers)
- Journals
- Infection and Immunity (29 papers)Clinical Infectious Diseases (24 papers)Antimicrobial Agents and Chemotherapy (22 papers)The Journal of Infectious Diseases (15 papers)PLoS Pathogens (6 papers)
- Partner nations
- United StatesBritish Virgin IslandsUnited Kingdom
In The Last Decade
John E. Edwards
233 papers receiving 27.5k citations
John E. Edwards's Hit Papers
Peers
Comparison fields: 5 of 198
- Infectious Diseases 16.9k
- Applied Microbiology and Biotechnology 1.6k
- Molecular Medicine 3.2k
- Epidemiology 12.0k
- Microbiology 1.8k
Countries citing papers authored by John E. Edwards
This map shows the geographic impact of John E. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Edwards more than expected).
Fields of papers citing papers by John E. Edwards
This network shows the impact of papers produced by John E. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Edwards. The network helps show where John E. Edwards may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Edwards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Hit paper breakdown → | 2008 | 4084 |
| 2 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2009 | 2512 |
| 3 | The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America Hit paper breakdown → | 2007 | 1319 |
| 4 | Guidelines for Treatment of Candidiasis Hit paper breakdown → | 2004 | 1143 |
| 5 | Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management Hit paper breakdown → | 2005 | 1075 |
| 6 | Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America Hit paper breakdown → | 2006 | 911 |
| 7 | A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia Hit paper breakdown → | 1994 | 862 |
| 8 | Practice Guidelines for the Treatment of Candidiasis Hit paper breakdown → | 2000 | 751 |
| 9 | Type 1/Type 2 Immunity in Infectious Diseases Hit paper breakdown → | 2001 | 717 |
| 10 | A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients Hit paper breakdown → | 2003 | 705 |
| 11 | Trends in Antimicrobial Drug Development: Implications for the Future Hit paper breakdown → | 2004 | 699 |
| 12 | 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever Hit paper breakdown → | 1997 | 527 |
| 13 | Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells Hit paper breakdown → | 2007 | 509 |
| 14 | 2006 | 452 | |
| 15 | 2009 | 402 | |
| 16 | 2008 | 401 | |
| 17 | 2009 | 388 | |
| 18 | 1978 | 346 | |
| 19 | 1995 | 307 | |
| 20 | 1982 | 295 |
About John E. Edwards
John E. Edwards is a scholar working on Infectious Diseases, Epidemiology, Oncology, Immunology and Ocean Engineering, having authored 250 papers that have together received 29.3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (132 papers), Fungal Infections and Studies (80 papers), Parasitic Diseases Research and Treatment (14 papers), Reservoir Engineering and Simulation Methods (12 papers), Nail Diseases and Treatments (11 papers), Drilling and Well Engineering (11 papers), Peptidase Inhibition and Analysis (11 papers) and Antimicrobial Peptides and Activities (11 papers). The work is most often cited by research in Infectious Diseases (16.9k citations), Applied Microbiology and Biotechnology (1.6k citations), Molecular Medicine (3.2k citations), Epidemiology (12.0k citations) and Microbiology (1.8k citations). John E. Edwards has collaborated with scholars based in United States, British Virgin Islands and United Kingdom. Frequent co-authors include Brad Spellberg, Ashraf S. Ibrahim, Scott G. Filler, John S. Bradley, David N. Gilbert, John Rex, George H. Talbot, Michael Scheld, Helen W. Boucher and Peter G. Pappas. Their work appears in journals such as Infection and Immunity, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.